ZBiotics Secures $12M Series A Funding to Advance Novel Probiotics nextdigitalhealth.com

Developer of the world’s first genetically modified probiotics, ZBiotics has secured $12 million in Series A funding round to meet the soaring consumer demand, support retail expansion, and drive research and development to bring more products to the market.

Co-founded in 2016 by Zachary Abbott and Stephen Lamb JD, the biotechnology startup develops genetically engineered probiotics designed to augment the functioning of human body systems, bringing new functionality to help the body handle everyday chemicals and contaminants.